The Adval Tech Group is selling injection molding businesses in Mexico and China to Phillips-Medisize, as it changes strategy to concentrate on moldmaking and select components, while Phillips-Medisize builds on a stated strategy of offering customers global manufacturing and design with local production and development capabilities. Phillips-Medisize said in a release that it intends on retaining all 350 employees, and will actually expand its drug delivery development engineering capabilities by adding three engineers. Tagging Options Domain:  All Sites Issue Date:  PT – July 2013 Keywords:  Phillips-Medisize Adval Tech medical injection molding drug delivery read more

Excerpt from:
Updated: Phillips-Medisize acquires Adval Tech injection molding units in China, Mexico